Ozempic ‘microdosing’ is new weight-loss trend
which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health ...
The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...
The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA).On Dec. 20, ...
Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...
HealthDay on MSN1d
Some GLP-1s Achieve More Weight Loss Than Others: StudyBy comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers found. Common adverse side effects from the drugs included nausea, vomiting, ...
In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
News Nation on MSN10d
FDA approves Zepbound for sleep apnea in obese adultsZepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, a swallowable, procedureless intragastric balloon, in adults with obesity.
The Washington Post on MSN9d
FDA approves weight-loss drug Zepbound to treat sleep apneaThe Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Glucagon-like peptide-1 receptor agonist drugs may reduce the risk of surgical complications in diabetic patients, according to a large new study. The study showed diabetic patients taking GLP-1 drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback